The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide
Open accessAbstract
The amyloid beta peptide 42 (Abeta(42)) plays a key role in neurotoxicity in Alzheimer's disease. Mononuclear phagocytes, i.e. microglia, have the potential to clear Abeta by phagocytosis. Recently, the lipopolysaccharide (LPS) receptor CD14 was shown to mediate phagocytosis of bacterial components and furthermore to contribute to neuroinflammation in Alzheimer's disease. Here, we investigated whether this key innate immunity receptor can interact with Abeta(42) and mediate phagocytosis of this peptide. Using flow cytometry, confocal microscopy and two-photon fluorescence lifetime imaging (FLIM) combined with fluorescence resonance energy transfer (FRET), we demonstrated a direct molecular interaction in the range of a few nanometers between Abeta(42) and CD14 in human CD14-transfected Chinese hamster ovary cells. Investigations using cells that were genetically deficient for this receptor showed that in <30 minutes exogenous Abeta(42) added to cultured primary microglial cells was phagocytosed into the cytoplasmic compartment in a CD14-dependent manner. This phagocytosis occurred at Abeta(42) concentration ranges that were considerably lower than the threshold to activate a cellular inflammatory reaction. In contrast, there was no association of CD14 to microglial internalization of microbeads. In complementary clinical experiments, we detected a pronounced CD14 immunoreactivity on parenchymal microglia spatially correlated to characteristic Alzheimer's disease lesion sites in brain sections of Alzheimer's disease patients but not in brain sections of control subjects. By showing a close interaction between CD14 and Abeta(42), demonstrating a direct role of CD14 in Abeta(42) phagocytosis, and detecting CD14-specific staining in brains of Alzheimer's disease patients, our results indicate a role of the LPS receptor in the pathophysiology of Alzheimer's disease, which could be of therapeutic relevance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516
Fluorescence Energy Transfer as a Spectroscopic Ruler
Stryer, L. (1978) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.47.070178.004131 · Cited by 2,406
Bard, F., Cannon, C., Barbour, R., Burke, R.-L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., et al. (2000) · Nature Medicine · doi:10.1038/78682 · Cited by 2,012
Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13287 · Cited by 1,507
Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability
Dahlgren, K. N., Manelli, A. M., Stine, W. B., Baker, L. K., Krafft, G. A., & LaDu, M. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201750200 · Cited by 1,452
Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease
Janus, C., Pearson, J., McLaurin, J., Mathews, P. M., Jiang, Y., Schmidt, S. D., Chishti, M. A., Horne, P., Heslin, D., French, J., et al. (2000) · Nature · doi:10.1038/35050110 · Cited by 1,431
Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report
Nicoll, J. A. R., Wilkinson, D., Holmes, C., Steart, P., Markham, H., & Weller, R. O. (2003) · Nature Medicine · doi:10.1038/nm840 · Cited by 1,397 · cited 2×
“Ab has been shown to injure neurons both directly and indirectly, via induction of chronic neuroinflammatory response (Games et al., 1995; McGeer and McGeer, 2003; Nicoll et al., 2003).”
BackgroundActivation of microglial cells by β-amyloid protein and interferon-γ
Meda, L., Cassatella, M. A., Szendrei, G. I., Otvos, L., Baron, P., Villalba, M., Ferrari, D., & Rossi, F. (1995) · Nature · doi:10.1038/374647a0 · Cited by 1,314
Regulation of Phagosome Maturation by Signals from Toll-Like Receptors
Blander, J. M., & Medzhitov, R. (2004) · Science · doi:10.1126/science.1096158 · Cited by 991 · cited 2×
“The need for the host cells to combat invading pathogens both by phagocytosis of pathogens and by release of cytotoxic products (Aderem, 2003; Blander and Medzhitov, 2004) may explain such a dual function of CD14 and other receptors, including scavenger receptor class B type I (Bocharov et al.”
BackgroundRelationship of microglia and astrocytes to amyloid deposits of Alzheimer disease
Itagaki, S., McGeer, P. L., Akiyama, H., Zhu, S., & Selkoe, D. (1989) · Journal of Neuroimmunology · doi:10.1016/0165-5728(89)90115-x · Cited by 940
Fassbender, K., Simons, M., Bergmann, C., Stroick, M., Lütjohann, D., Keller, P., Runz, H., Kühl, S., Bertsch, T., von Bergmann, K., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081620098 · Cited by 860
Self-citationHaziot, A., Ferrero, E., Köntgen, F., Hijiya, N., Yamamoto, S., Silver, J., Stewart, C. L., & Goyert, S. M. (1996) · Immunity · doi:10.1016/s1074-7613(00)80254-x · Cited by 743
Human CD14 mediates recognition and phagocytosis of apoptotic cells
Devitt, A., Moffatt, O. D., Raykundalia, C., Capra, J. D., Simmons, D. L., & Gregory, C. D. (1998) · Nature · doi:10.1038/33169 · Cited by 681
Paresce, D. M., Ghosh, R. N., & Maxfield, F. R. (1996) · Neuron · doi:10.1016/s0896-6273(00)80187-7 · Cited by 663
Dependence of α-Synuclein Aggregate Morphology on Solution Conditions
Hoyer, W., Antony, T., Cherny, D., Heim, G., Jovin, T. M., & Subramaniam, V. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00775-1 · Cited by 565
Self-citationIdentification of two lysosomal membrane glycoproteins.
Chen, J. W., Murphy, T. L., Willingham, M. C., Pastan, I., & August, J. T. (1985) · The Journal of cell biology · doi:10.1083/jcb.101.1.85 · Cited by 485
Inflammatory processes in Alzheimer's disease
McGeer, E. G., & McGeer, P. L. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(03)00124-6 · Cited by 472
Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice
Wyss-Coray, T., Yan, F., Lin, A. H.-T., Lambris, J. D., Alexander, J. J., Quigg, R. J., & Masliah, E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162350199 · Cited by 446 · cited 2×
“Indeed, inhibition of complement 3 in a mouse model of Alzheimer’s disease increased plaque formation and neuro- degeneration (Wyss-Coray et al., 2002).”
BackgroundDIVERGENT ROLES FOR F c RECEPTORS AND COMPLEMENT IN VIVO
Ravetch, J. V., & Clynes, R. A. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.421 · Cited by 366
The LPS receptor (CD14) links innate immunity with Alzheimer's disease
Fassbender, K., Walter, S., Kühl, S., Landmann, R., Ishii, K., Bertsch, T., Stalder, A. K., Muehlhauser, F., Liu, Y., Ulmer, A. J., et al. (2004) · The FASEB Journal · doi:10.1096/fj.03-0364fje · Cited by 307
Self-citationPhagocytosis and the Inflammatory Response
Aderem, A. (2003) · The Journal of Infectious Diseases · doi:10.1086/374747 · Cited by 304
Glycosylation of CD44 negatively regulates its recognition of hyaluronan.
Katoh, S., Zheng, Z., Oritani, K., Shimozato, T., & Kincade, P. W. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.2.419 · Cited by 254
Divergent Response to LPS and Bacteria in CD14-Deficient Murine Macrophages
Moore, K. J., Andersson, L. P., Ingalls, R. R., Monks, B. G., Li, R., Arnaout, M. A., Golenbock, D. T., & Freeman, M. W. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.8.4272 · Cited by 226
Le Cabec, V., Carréno, S., Moisand, A., Bordier, C., & Maridonneau-Parini, I. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.4.2003 · Cited by 213
The role of complement and activated microglia in the pathogenesis of Alzheimer's disease
Eikelenboom, P., & Veerhuis, R. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00108-x · Cited by 206
CD14 signalling in lipid rafts: new ligands and co-receptors
Schmitz, G., & Orsó, E. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200210000-00007 · Cited by 196
Nerve inflammation halts trial for Alzheimer's drug
Check, E. (2002) · Nature · doi:10.1038/415462a · Cited by 176
BORCHARDT, T., CAMAKARIS, J., CAPPAI, R., MASTERS, C. L., BEYREUTHER, K., & MULTHAUP, G. (1999) · Biochemical Journal · doi:10.1042/bj3440461 · Cited by 171
CD14 receptor-mediated uptake of nonopsonized Mycobacterium tuberculosis by human microglia
Peterson, P. K., Gekker, G., Hu, S., Sheng, W. S., Anderson, W. R., Ulevitch, R. J., Tobias, P. S., Gustafson, K. V., Molitor, T. W., & Chao, C. C. (1995) · Infection and Immunity · doi:10.1128/iai.63.4.1598-1602.1995 · Cited by 167
Amyloid-β Immunization Effectively Reduces Amyloid Deposition in FcRγ-/-Knock-Out Mice
Das, P., Howard, V., Loosbrock, N., Dickson, D., Murphy, M. P., & Golde, T. E. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-24-08532.2003 · Cited by 165
Alzheimer's disease: treatments in discovery and development
Citron, M. (2002) · Nature Neuroscience · doi:10.1038/nn940 · Cited by 165
Bacskai, B. J., Skoch, J. M., Hickey, G. A., Allen, R., & Hyman, B. T. (2003) · Journal of Biomedical Optics · doi:10.1117/1.1584442 · Cited by 159
Microglia, amyloid and dementia in Alzheimer disease
Arends, Y. M., Duyckaerts, C., Rozemuller, J. M., Eikelenboom, P., & Hauw, J.-J. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00094-4 · Cited by 139
Golenbock, D. T., Liu, Y., Millham, F. H., Freeman, M. W., & Zoeller, R. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80647-4 · Cited by 131
Self-citationCD14-dependent Endotoxin Internalization via a Macropinocytic Pathway
Poussin, C., Foti, M., Carpentier, J., & Pugin, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20285 · Cited by 106
YAZAWA, H., YU, Z.-X., TAKEDA, K., LE, Y., GONG, W., FERRANS, V. J., OPPENHEIM, J. J., LI, C. C. H., & WANG, J. M. (2001) · The FASEB Journal · doi:10.1096/fj.01-0251com · Cited by 105
Internalization of Monomeric Lipopolysaccharide Occurs after Transfer Out of Cell Surface Cd14
Vasselon, T., Hailman, E., Thieringer, R., & Detmers, P. A. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.4.509 · Cited by 76
Bocharov, A. V., Baranova, I. N., Vishnyakova, T. G., Remaley, A. T., Csákó, G., Fairwell, T., Patterson, A. P., & Eggerman, T. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314264200 · Cited by 74
Ishii, K., Muelhauser, F., Liebl, U., Picard, M. A., Kühl, S., Penke, B., Bayer, T. A., Wießler, M., Hennerici, M. G., Beyreuther, K. T., et al. (2000) · The FASEB Journal · doi:10.1096/fj.99-0786com · Cited by 69
Self-citationSpecificity of mechanisms for plaque removal after Aβ immunotherapy for Alzheimer disease
Akiyama, H., & McGeer, P. L. (2004) · Nature Medicine · doi:10.1038/nm0204-117 · Cited by 55
Synergistic effect of colchicine and cytochalasin D on phagocytosis by peritoneal macrophages
Mimura, N., & ASANO, A. (1976) · Nature · doi:10.1038/261319a0 · Cited by 54
Borchardt, T., Camakaris, J., Cappai, R., Masters, C. L., Beyreuther, K. T., & Multhaup, G. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3440461 · Cited by 53
Huang, F., Buttini, M., Wyss-Coray, T., McConlogue, L., Kodama, T., Pitas, R. E., & Mucke, L. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65489-2 · Cited by 49
Microglia kill amyloid-β1-42 damaged neurons by a CD14-dependent process
Bate, C., Veerhuis, R., Eikelenboom, P., & Williams, A. (2004) · Neuroreport · doi:10.1097/01.wnr.0000132203.76836.16 · Cited by 46
Muro, M., Koseki, T., Akifusa, S., Kato, S., Kowashi, Y., Ohsaki, Y., Yamato, K., Nishijima, M., & Nishihara, T. (1997) · Infection and Immunity · doi:10.1128/iai.65.4.1147-1151.1997 · Cited by 41
Ishii, K. (2000) · The FASEB Journal · doi:10.1096/fj.14.11.1485 · Cited by 38
Phagocytosis of NonopsonizedCryptococcus neoformansby Swine Microglia Involves CD14 Receptors
Lipovsky, M. M., Gekker, G., Anderson, W. R., Molitor, T. W., Peterson, P. K., & Hoepelman, A. I. M. (1997) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1997.4381 · Cited by 35
Cited by
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
Kettenmann, H., Hanisch, U.-K., Noda, M., & Verkhratsky, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00011.2010 · Cited by 3,547
The NALP3 inflammasome is involved in the innate immune response to amyloid-β
Halle, A., Hornung, V., Petzold, G. C., Stewart, C. R., Monks, B. G., Reinheckel, T., Fitzgerald, K. A., Latz, E., Moore, K. J., & Golenbock, D. T. (2008) · Nature Immunology · doi:10.1038/ni.1636 · Cited by 2,441
The Amyloid-β Pathway in Alzheimer’s Disease
Hampel, H., Hardy, J., Blennow, K., Chen, C., Perry, G., Kim, S. H., Villemagne, V. L., Aisen, P., Vendruscolo, M., Iwatsubo, T., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01249-0 · Cited by 1,952
TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling
Ciesielska, A., Matyjek, M., & Kwiatkowska, K. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03656-y · Cited by 1,420
Metadata
- Authors
- Liu, Y., Walter, S., Stagi, M., Cherny, D., Letiembre, M., Schulz-Schaeffer, W., Heine, H., Penke, B., Neumann, H., & Fassbender, K.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-08-01
- Volume
- 128
- Issue
- 8
- Pages
- 1778-1789
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2153126018
- Cited by
- 349
- References
- 48
- FWCI
- 7.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.